CovalX
Zurich, CH · 1 known investors
Find your way into CovalX
Sign up to see every warm intro you have to CovalX
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CovalX team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CovalX provides mass spectrometry-based analytical services for biotherapeutic development, including epitope mapping, de novo sequencing, and monoclonal antibody characterization. It serves pharmaceutical and biotechnology companies across Europe and the United States, supporting drug discovery and development.
Investors · 1
Frequently asked questions
- What does CovalX do?
- CovalX provides mass spectrometry-based analytical services for biotherapeutic development, including epitope mapping, de novo sequencing, and monoclonal antibody characterization. It serves pharmaceutical and biotechnology companies across Europe and the United States, supporting drug discovery and development.
- Who are CovalX's investors?
- CovalX's investors include StartAngels Network.
- Where is CovalX headquartered?
- CovalX is headquartered in Zurich, CH.
